Accurate diagnosis of pleural disease is crucial to patient care. With the increasing need for pathologists to order and interpret molecular testing for lung carcinomas and other pulmonary tumors, this course provides essential insights. Led by expert pathologists, you’ll dive into common diagnostic pitfalls in thoracic pathology, cytology, and immunohistochemistry, alongside new cases of mediastinal tumors, pleural tumors, and non-neoplastic lung disease.
As molecular testing becomes more mainstream, interpreting these tests for lung carcinomas and other pulmonary tumors is of vital importance. Our faculty will discuss key issues related to molecular testing, focusing on what to order, when to order, and how to interpret the results. This comprehensive course features engaging lectures and interactive case-based discussions, designed to enhance your diagnostic proficiency.
Learning Objectives
- Understand when molecular testing is needed for thoracic tumors, identify appropriate tests, and interpret results accurately.
- Become familiar with the morphologic features of various prevascular mediastinal lesions to establish a reasonable differential diagnosis and apply small panels of ancillary tests like immunostains and cytogenetics.
- Gain insights into the morphologic features of non-neoplastic lung diseases, exploring cases that include cellular and fibrotic interstitial pneumonias, smoking-related disease, cystic lung disease, and more.
- Understand the various types of pleural lesions in everyday practice, their morphologic differentials and mimics, and the usefulness of adjunctive tests.
- Enhance your familiarity with thoracic cytology (lavage, EBUS, effusion) specimens, specimen preparation issues…
Reviews
There are no reviews yet.